Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference28 articles.
1. Cury DB, MeS Cury, Elias GV, Mizsputen SJ. Infliximab to treat severe ulcerative colitis. World J Gastroenterol. 2009;15:1771–3.
2. Feuerstein JD, Isaacs KL, Schneider Y et al. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology. 2020. https://doi.org/10.1053/j.gastro.2020.03.012.
3. Singh S, Fumery M, Sandborn WJ, Murad MH. Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis. Alimentary Pharmacology & Therapeutics. 2018;47:162–175.
4. Jia X, Guo R, Hu Z et al. Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis. Medicine (Baltimore). 2020;99:e22894.
5. Hodge JA, Kawabata TT, Krishnaswami S et al. The mechanism of action of tofacitinib-an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2016;34:318–328.